Form 4: Molina Healthcare Director Receives Stock Grant
Statement of Changes in Beneficial Ownership
Molina Healthcare, Inc. reports a stock grant to Director Francis S. Soistman Jr. under the 2025 Equity Incentive Plan.
Summary
- Francis S. Soistman Jr., a Director at Molina Healthcare, Inc., received a grant of 237 shares of common stock on July 1, 2026.
- This grant is part of the Issuer's 2025 Equity Incentive Plan, awarded in connection with his services as a Director.
- The annual equity award for directors is valued at $220,000, with one-quarter ($55,000) granted each quarter.
- The number of shares granted is based on the closing price of the Issuer's common stock on the grant date.
- On July 1, 2026, the closing price was $232.55 per share, resulting in the 237-share grant.
- Following the transaction, Mr. Soistman beneficially owns 907 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine stock grant to a director as part of an established compensation plan, with no significant new financial information or strategic shifts.
Positives
- Director compensation aligns with company performance through stock grants tied to closing prices.
- The company has a structured equity incentive plan to reward directors.
- The grant is part of a regular quarterly award, indicating consistent compensation practices.
Future Outlook
The filing does not contain specific forward-looking statements or guidance. It reports a completed transaction of a stock grant.
Industry Context
StockSavvy.ai notes that equity grants to directors are a common practice in the healthcare industry to align executive and director interests with those of shareholders and incentivize long-term performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Francis Soistman Jr. granted a Limited Power of Attorney to Jeff D. Barlow and Codruta Boggs for executing Section 16(a) filings. | 04/17/2026 | Facilitates timely and accurate filing of SEC forms related to beneficial ownership changes. |
Stakeholder Impact
- Shareholders: The stock grant aligns director interests with shareholder value creation and reflects ongoing compensation practices.
- Employees: The filing does not directly impact employees, but the incentive structure for directors can indirectly influence company strategy and performance.
- Management: The filing is a standard disclosure for management and directors regarding their holdings and transactions.
Next Steps
- Continued quarterly stock grants to directors as per the 2025 Equity Incentive Plan.
- Ongoing reporting of beneficial ownership changes by directors and officers.
Key Dates
| Date | Description |
|---|---|
| 04/17/2026 | Date of execution for the Limited Power of Attorney for Section 16(a) Filings by Francis Soistman. |
| 07/01/2026 | Transaction date for the stock grant to Francis S. Soistman Jr. and the closing price date for the stock. |
| 07/02/2026 | Date of signature for the Form 4 filing. |
Keywords
Molina Healthcare, MOH, Form 4, Stock Grant, Director Compensation, Equity Incentive Plan, SEC Filing, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.